AGP Executive Report
Last update: 8 hours agoDiabetes Tech in the Spotlight (ADA 2026): New Orleans hosted major diabetes updates, including the ADA’s Innovation Challenge winners—Adaptyx Biosciences, Nymble Health, and Silverstream Medical—plus new trial and real-world data pushing continuous glucose monitoring further into non-insulin type 2 care. New Evidence on CGM Use: The CONNECT randomized trial reported clinically meaningful A1C reductions for adults with type 2 diabetes not using insulin, while additional real-world results highlighted sustained performance for implantable Eversense 365 in both open- and closed-loop systems. Obesity Drug Momentum (ADA 2026): Phase 3 retatrutide results were presented for both type 2 diabetes and obesity/overweight, with researchers pointing to weight loss and improvements tied to conditions like obstructive sleep apnea and knee osteoarthritis. Louisiana Politics (U.S. Senate): In Southwest Louisiana, candidates Julia Letlow and John Fleming made their cases ahead of the June 27 runoff, including sharp differences on carbon capture. Energy & Costs (Gas Prices): GasBuddy reported some of the week’s lowest local regular and premium prices across multiple parishes, while broader coverage tied volatility to global oil and refinery conditions. Local Business & Jobs: St. Landry Parish economic development lost longtime director Bill Rodier, a key figure in growth along the I-49 corridor.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
Pseudo-journalism: Pink-slime
